Associations of oseltamivir with neuropsychiatric and behavioral adverse events: A systematic review and meta-analysis
{{output}}
Background: Influenza causes approximately 3-5 million severe cases and 290,000-650,000 deaths annually, and oseltamivir is considered the first-line pharmacotherapy. Recent reports on neuropsychiatric events (NPEs) associated wi... ...
